Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about DMT Entities

Recent news which mentions DMT Entities

Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
Tickers ATAI CMPS DMTTF DRUG
Tags Small Cap Financing DRUG
From Benzinga
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
Tickers DMTTF
Tags DMT Entities Psychedelic/Assisted Therapies Psychedelics
From Benzinga
Small Pharma's IP Portfolio Grows With Numerous Approved Patent Applications Around The World
Tickers DMTTF
Tags Penny Stocks DMTTF News
From Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
Tickers CYBN
Tags CYBN Markets DMT Entities
From Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
Tickers CYBN
Tags Penny Stocks News Market News
From Benzinga
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
Tickers DMTTF
Tags major depressive disorder Psychedelic/Assisted Therapies DMT Entities
From Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
Tickers AGNPF
Tags Psychedelic/Assisted Therapies Human Stroke DMT Entities
From Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
Tickers DMTTF
Tags Psychedelic/Assisted Therapies Short/Acting Psychedelics DMT Entities
From Benzinga
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
Tickers LMLLF PHRRF
Tags DMT Entities PHRRF Psychedelic/Assisted Therapies
From Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
Tickers AGNPF TBI
Tags Psychedelics Benzinga AGN Neuro
From Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
Tickers AGNPF
Tags Global Markets AGNPF
From Benzinga
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
Tickers DMTTF
Tags Next/Generation Psychedelics Global Market News
From Benzinga
Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment
Tickers CYBN
Tags Global Markets Psilocybin
From Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
Tickers DMTTF
Tags DMT Entities Management Short/Acting Psychedelics
From Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
Tickers DMTTF
Tags major depressive disorder Cannabis Market News
From Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
Tickers CYBN
Tags Generalized Anxiety Disorder Benzinga Psychedelics
From Benzinga
Encountering DMT Entities: Are They Real?
Tickers DMT
Tags Market News Cannabis Markets
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.